Cell by cell immuno- and cancer marker profiling of non-small cell lung cancer tissue: Checkpoint marker expression on CD103+, CD4+ T-cells predicts circulating tumor cells

Non-small cell lung cancer (NSCLC) has a poor prognosis. Targeted therapy and immunotherapy in recent years has significantly improved NSCLC patient outcome. In this study, we employed cell-by-cell immune and cancer marker profiling of the primary tumor cells to investigate possible signatures that...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoyang, Jaimes, Maria, Gu, Huimin, Shults, Keith, Putta, Santosh, Sharma, Vishal, Chow, Will, Gogoi, Priya, Handique, Kalyan, Patterson, Bruce K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683336/
https://www.ncbi.nlm.nih.gov/pubmed/33217647
http://dx.doi.org/10.1016/j.tranon.2020.100953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683336/
https://www.ncbi.nlm.nih.gov/pubmed/33217647
http://dx.doi.org/10.1016/j.tranon.2020.100953

Ejemplares similares